PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

ADRe Profile Surfaces Hidden Medication Harms in Primary Care

ADRe Profilemedication safetypolypharmacydeprescribingadverse drug reactionsprimary careolder adultscluster RCTmedicines optimisationpharmacist reviewflecainidemetforminvitamin B12 Medication Safety

Background Information

ADRe Profile improves medication safety for elderly on multiple prescriptions.

Incomplete monitoring of repeat prescriptions can lead to avoidable harm, especially in older adults on multiple medications. The intervention group using the Adverse Drug Reaction (ADRe) Profile had more problems addressed compared to controls (82% vs. 35%, adjusted odds ratio 7.48, 95% CI 1.99 to 28.10). The study shows that the ADRe Profile can significantly benefit patients by identifying and addressing clinical problems; however, implementation challenges exist regarding staff time. The ADRe Profile effectively reduces risk of suboptimal prescribing and iatrogenic harm in primary care.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

Authors: Logan V, Conboy A, Carter N, Hughes D, Turner A, Watkins A, Jordan S

Citation: Logan V, Conboy A, Carter N, et al. "A better system" - managing the adverse effects of prescribed medicines: Cluster-randomised controlled trial and process evaluation of the ADRe Profile in primary care. PloS one. 2026;21(9):e0356480. doi:10.1371/journal.pone.0356480

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.